C57BL/6JCya-Clec5aem1/Cya
Common Name
Clec5a-KO
Product ID
S-KO-06978
Backgroud
C57BL/6JCya
Strain ID
KOCMP-23845-Clec5a-B6J-VA
When using this mouse strain in a publication, please cite “Clec5a-KO Mouse (Catalog S-KO-06978) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Clec5a-KO
Strain ID
KOCMP-23845-Clec5a-B6J-VA
Gene Name
Product ID
S-KO-06978
Gene Alias
Mdl1, Ly100, MDL-1, Clecsf5
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 6
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000129948
NCBI RefSeq
NM_001038604
Target Region
Exon 2~7
Size of Effective Region
~7.4 kb
Overview of Gene Research
CLEC5A, a spleen tyrosine kinase (Syk)-coupled C-type lectin, is highly expressed by monocytes, macrophages, neutrophils, and dendritic cells. It acts as a pattern recognition receptor, binding to terminal fucose and mannose moieties of viral glycans, as well as N -acetylglucosamine (GlcNAc) and N -acetylmuramic acid (MurNAc) disaccharides of bacterial cell walls. CLEC5A mediates microbe-induced inflammatory responses via Syk activation and is thus crucial in both septic and aseptic inflammatory reactions [1].
In various disease models, CLEC5A has shown significant roles. In a mosquito-to-mouse ZIKV disease model, CLEC5A knockout mice (clec5a-/-stat1-/-) had reduced testicular ZIKV titer, local inflammation, neutrophil invasion, and improved spermatozoa function compared to ZIKV-infected stat1-/-mice, indicating its role in ZIKV-induced orchitis and oligospermia [2]. In SARS-CoV-2 studies, antagonistic mAbs against CLEC5A inhibited COVID-19-EVs-induced NET formation, and clec5a-/-/tlr2-/-mice had attenuated thromboinflammation, highlighting CLEC5A's role in SARS-CoV-2-induced lung inflammation [3]. In Pseudomonas aeruginosa-induced pneumonia, blockade of CLEC5A attenuated NETosis and lung injury, and co-administration of anti-CLEC5A mAb with ciprofloxacin increased the survival rate of mice challenged with a lethal dose of P. aeruginosa [4].
In conclusion, CLEC5A is a key pattern recognition receptor mediating microbe-induced inflammatory responses. Gene knockout mouse models have revealed its significant roles in viral-induced inflammatory diseases such as ZIKV-induced testicular damage, SARS-CoV-2-induced lung inflammation, and bacterial-induced acute lung injury, providing potential therapeutic targets for these diseases.
References:
1. Sung, Pei-Shan, Chang, Wei-Chiao, Hsieh, Shie-Liang. . CLEC5A: A Promiscuous Pattern Recognition Receptor to Microbes and Beyond. In Advances in experimental medicine and biology, 1204, 57-73. doi:10.1007/978-981-15-1580-4_3. https://pubmed.ncbi.nlm.nih.gov/32152943/
2. Wang, Hsin-Wei, Li, Hsing-Han, Wu, Shih-Cheng, Chen, Chun-Hong, Hsieh, Shie-Liang. 2023. CLEC5A mediates Zika virus-induced testicular damage. In Journal of biomedical science, 30, 12. doi:10.1186/s12929-023-00906-6. https://pubmed.ncbi.nlm.nih.gov/36803804/
3. Sung, Pei-Shan, Yang, Shao-Ping, Peng, Yu-Chun, Tao, Mi-Hwa, Hsieh, Shie-Liang. 2022. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation. In Journal of biomedical science, 29, 52. doi:10.1186/s12929-022-00832-z. https://pubmed.ncbi.nlm.nih.gov/35820906/
4. Sung, Pei-Shan, Peng, Yu-Chun, Yang, Shao-Ping, Chiu, Cheng-Hsun, Hsieh, Shie-Liang. 2022. CLEC5A is critical in Pseudomonas aeruginosa-induced NET formation and acute lung injury. In JCI insight, 7, . doi:10.1172/jci.insight.156613. https://pubmed.ncbi.nlm.nih.gov/36048544/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
